Home
Invivoscribe

Invivoscribe Market Share Analysis for June 2026

Learn how Invivoscribe safeguards your personal data and ensures compliance with privacy regulations. Please read our full privacy policy for more details.

Science and Education > Biology

Domaininvivoscribe.com

Year Founded1995

Employees201 - 500

Annual Revenue$25M - $50M

Invivoscribe

Invivoscribe (including company regionals)

invivoscribe.com

See more website traffic and engagement information

Invivoscribe Revenue up to June 2026 is 25M - 50M

revenue generated by Invivoscribe top domains

Invivoscribe top domains revenue over 3 years

Revenue for Invivoscribe top domains

invivoscribe.com25M - 50M

See more with Sales Intelligence

Total visits to Invivoscribe's top domains

Understand Invivoscribe market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

invivoscribe.com7.7K

See more with Sales Intelligence

Avg. visit duration in Invivoscribe's top domains

Analyze Invivoscribe engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

invivoscribe.com00:00:21

See more with Sales Intelligence

Avg. pageviews on Invivoscribe's top domains

See how Invivoscribe keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

invivoscribe.com1.78

See more with Sales Intelligence

Invivoscribe top competitors by domain

Top similar sites in June 2026, ranked by their affinity

rosalind.bioCompany NameRosalindEmployees51 - 200HQUnited States, California, San DiegoAnnual revenue--Total visits8.1KScience and Education > Biology

Top technologies used by Invivoscribe

These are the website technologies, by industry, used by Invivoscribe top domains

Payment & Currencies (10)

Cart Functionality

Advertising (7)

DoubleClick

Conversion & Analytics (7)

Google Analytics

Widget (6)

reCAPTCHA

More Technologies

14

See all

News & Signals from Invivoscribe

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsInvivoscribe launches automated system integrating nucleic acid extraction and quantification.Invivoscribe launches automated system integrating nucleic acid extraction and quantification.

NewsHitachi partnered with Invivoscribe on May 10th '22.Since 2022, Hitachi High-Tech and Invivoscribe have been collaborating*[1] to create new value in the field of molecular diagnostics. The initiative involves combining Invivoscribe's technology, assay and bioinformatics development, global clinical testing, and international regulatory expertise with Hitachi High-Tech's core capabilities in automation, measurement and analysis in order to carry out research and development aimed at providing solutions relating to cancer diagnosis and monitoring through the course of therapy.

NewsInvivoscribe launches IdentiClone Dx IGH Assay certification.Invivoscribe(R) expands IVDR portfolio with IdentiClone(R) Dx IGH Assay certification.